|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
4
|
Resverlogix Corp.
|
May 03, 2021 05:57AM
|
|
Re: OTC Short Interest drops significantly from 729,105 to 475,882 -34.80% as of 03/31
|
4
|
Resverlogix Corp.
|
Apr 20, 2022 07:28PM
|
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 14, 2019 05:43AM
|
|
Re: TNBC no longer active?
|
4
|
Zenith Epigenetics
|
Jul 02, 2023 12:30PM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
4
|
Resverlogix Corp.
|
May 12, 2019 07:04AM
|
|
Re: The last couple of minutes of Tax Loss Selling
|
4
|
Resverlogix Corp.
|
Dec 27, 2019 05:08PM
|
|
Re: Sneaking Suspicion...
|
4
|
Resverlogix Corp.
|
Feb 05, 2021 07:27AM
|
|
VOLUME
|
4
|
Resverlogix Corp.
|
Jun 28, 2021 11:23AM
|
|
Re: Right of first refusal
|
4
|
Resverlogix Corp.
|
Mar 03, 2019 05:31AM
|
|
Annual Financial Reporting
|
4
|
Zenith Epigenetics
|
Mar 22, 2024 12:55PM
|
|
Re: Lu stepping down
|
4
|
Resverlogix Corp.
|
Apr 25, 2024 02:51PM
|
|
Re: What if HL ends ip owning RVX...
|
4
|
Resverlogix Corp.
|
Feb 15, 2019 07:54AM
|
|
Re: Hope never dies....
|
4
|
Resverlogix Corp.
|
Jun 04, 2021 09:31AM
|
|
Re: Price
|
4
|
Resverlogix Corp.
|
Dec 31, 2020 04:35PM
|
|
Re: Zenith funding???
|
4
|
Zenith Epigenetics
|
Jun 25, 2019 12:45PM
|
|
Re: Trading
|
4
|
Zenith Epigenetics
|
Sep 20, 2022 06:22PM
|
|
Re: Share price, why we stay
|
4
|
Resverlogix Corp.
|
Nov 15, 2020 11:32PM
|
|
Re: Rumors....
|
4
|
Resverlogix Corp.
|
Nov 21, 2019 11:13AM
|
|
Re: Help on Short Interest Please
|
4
|
Resverlogix Corp.
|
Mar 07, 2019 01:07PM
|
|
Re: Technical strength versus fundamental weakness....
|
4
|
Resverlogix Corp.
|
Mar 31, 2019 04:43PM
|
